These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 660533)
21. Introduction of quantitative methods in pharmacology and clinical pharmacology: a historical overview. Atkinson AJ; Lalonde RL Clin Pharmacol Ther; 2007 Jul; 82(1):3-6. PubMed ID: 17571065 [No Abstract] [Full Text] [Related]
22. On nonoscillation and monotonicity of solutions of nonnegative and compartmental dynamical systems. Chellaboina V; Haddad WM; Bailey JM; Ramakrishnan J IEEE Trans Biomed Eng; 2004 Mar; 51(3):408-14. PubMed ID: 15000372 [TBL] [Abstract][Full Text] [Related]
23. Methods for deriving pesticide aquatic life criteria. TenBrook PL; Tjeerdema RS; Hann P; Karkoski J Rev Environ Contam Toxicol; 2009; 199():19-109. PubMed ID: 19110939 [TBL] [Abstract][Full Text] [Related]
24. A model of non-exclusive binding of agonist and antagonist on G-protein coupled receptors. Järv J J Theor Biol; 1995 Aug; 175(4):577-82. PubMed ID: 7475093 [TBL] [Abstract][Full Text] [Related]
25. [Quantitative approach for calculation of pharmacodynamic interactions and simulation of combined response]. Chen JC; Pan YJ; Li XS; Sun J; Liu HX; Sun RY; Zheng QS Zhongguo Zhong Yao Za Zhi; 2008 Aug; 33(16):2029-33. PubMed ID: 19086647 [TBL] [Abstract][Full Text] [Related]
27. Drugs and nondrugs: an effective discrimination with topological methods and artificial neural networks. Murcia-Soler M; Pérez-Giménez F; García-March FJ; Salabert-Salvador MT; Díaz-Villanueva W; Castro-Bleda MJ J Chem Inf Comput Sci; 2003; 43(5):1688-702. PubMed ID: 14502504 [TBL] [Abstract][Full Text] [Related]
28. Characterization of bombesin receptors using a novel, potent, radiolabeled antagonist that distinguishes bombesin receptor subtypes. Mantey S; Frucht H; Coy DH; Jensen RT Mol Pharmacol; 1993 May; 43(5):762-74. PubMed ID: 7684815 [TBL] [Abstract][Full Text] [Related]
29. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis. de Boer SF; Koolhaas JM Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183 [TBL] [Abstract][Full Text] [Related]
30. Nonlinear response surface in the study of interaction analysis of three combination drugs. Wan W; Pei XY; Grant S; Birch JB; Felthousen J; Dai Y; Fang HB; Tan M; Sun S Biom J; 2017 Jan; 59(1):9-24. PubMed ID: 27185067 [TBL] [Abstract][Full Text] [Related]
31. Functional methods for quantifying agonists and antagonists. Dougall LG J Recept Signal Transduct Res; 2001; 21(2-3):117-37. PubMed ID: 11757680 [TBL] [Abstract][Full Text] [Related]
32. The Cheng-Prusoff relationship: something lost in the translation. Craig DA Trends Pharmacol Sci; 1993 Mar; 14(3):89-91. PubMed ID: 8488569 [TBL] [Abstract][Full Text] [Related]
35. Scientific method in the evolution of new drugs; the cell surface and drug action. ROBERTSON RN Aust J Sci; 1945 Feb; 7():112-8. PubMed ID: 20996348 [No Abstract] [Full Text] [Related]
36. [Unity through diversity: the use of multivariate methods in drug research]. Mager PP Pharm Unserer Zeit; 1984 Sep; 13(5):147-55. PubMed ID: 6494205 [No Abstract] [Full Text] [Related]
37. [Selection criteria for statistical significance test in confirmatory pharmacological studies]. Nakanishi N Nihon Yakurigaku Zasshi; 2017; 150(1):10-15. PubMed ID: 28690269 [No Abstract] [Full Text] [Related]
39. pA, a new scale for the measurement of drug antagonism. SCHILD HO Br J Pharmacol Chemother; 1947 Sep; 2(3):189-206. PubMed ID: 20258355 [No Abstract] [Full Text] [Related]
40. The design of pharmacological experiments using unbiased models of agonist-antagonist interaction. Vere DW J Pharmacol Exp Ther; 1978 Jun; 205(3):617-23. PubMed ID: 660533 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]